Show results for
Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Disease Target Equipment Supplied In Europe
20 equipment items found
by:Genome Biologics based inFrankfurt am Main, GERMANY
GENIMAPS® and GENISYST® technology integration facilitates Ai-driven target identification, and direct therapeutic interrogation of RNAi disease targets in vitro (2D and 3D), and in small and large animal models. This coupled workflow enables efficient and accelerated RNAi target discovery and efficacy ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
AD1801 is an innovative project to develop disease modifying treatment of Alzheimer’s disease, targeting Apolipoprotein E (ApoE), a different molecule than those targeted in the projects BAN2401 and BAN2401 ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs is held back by properties that ...
Manufactured by:Roche Diagnostics International AG based inRotkreuz, SWITZERLAND
The XT-8 system is the pioneer of true multiplex molecular testing, offering post-PCR detection for infectious disease, genetics, and pharmacogenetics ...
Manufactured by:Novo Nordisk A/S based inBagsværd, DENMARK
Our proprietary GalXC technology leverages a naturally occurring biologic process, ribonucleic acid interference, RNAi, to create therapies that silence disease-causing genes. This platform enables Dicerna to create molecules that can effectively interfere with the RNAi processes that lead to defective or misregulated proteins that cause disease. ...
Manufactured by:Omega Diagnostics Group PLC based inAlva, UNITED KINGDOM
VISITECT® CD4 Advanced Disease supports the identification of advanced disease in people living with HIV. VISITECT® CD4 Advanced Disease is a unique, instrument-free, rapid and disposable CD4 test benefiting patients and healthcare ...
Manufactured by:Dollvet based inGüngören, TURKEY
Pharmaceutical Form :Injectable Solution. It is applied for protection in sheep and goats against Enterotoxemia and Infectious Necrotic Hepatitis, In Lambs and kids against Enterotoxemia, In cattle against Enterotoxemia and Blackleg ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
Better target discovery and compound design in Ulcerative Colitis. What is UC?: Ulcerative colitis (UC) is a chronic, lifelong disease that causes inflammation and ulceration of the inner lining of the colon and rectum, accompanied by debilitating symptoms. ...
Manufactured by:Singleron Biotechnologies GmbH based inKöln, GERMANY
GEXSCOPE Single Cell V(D)J Kit enables simultaneous detection of T-cell or B-cell receptor gene expression, together with whole transcriptome expression at single-cell ...
Manufactured by:Exscientia based inOxford, UNITED KINGDOM
Target selection is key to creating success in drug discovery. Selecting each target is a significant decision and the future success of any molecule will depend on that initial ...
by:Hookipa Pharma Inc. based inVienna, AUSTRIA
The immune system is the body’s natural defense mechanism against pathogens. Our proprietary technology is capable of targeting and treating disease with a tailored immune response. Our science is based on a novel and highly differentiated delivery platform based on arenaviruses, a family of naturally-occurring ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
The Benevolent Platform™ is our powerful computational R&D platform. At its core sits our Knowledge Graph, which captures the interconnectivity of all relevant available data and scientific literature. Our suite of exploratory and predictive AI tools allow scientists to interrogate the data and disease networks within the graph, ask biological questions, surface novel ...
Manufactured by:DiagNodus Ltd. based inCambridge, UNITED KINGDOM
DiagNodus has designed and patented methods for non-invasive collection and analysis of samples indicative of the state of the human bowel. The technology is based upon disease biomarker detection. The approach addresses a range of diagnostic, screening and monitoring applications within the field of colorectal disease, in particular targeting ...
Manufactured by:CLONIT srl based inAbbiategrasso, ITALY
The AML1-ETO t(8;21)(q22;q22) is an in vitro diagnostic test for the identification and quantification of the AML1-ETO gene fusion transcripts resulting from t(8;21)(q22;q22) , by one-step Real-Time PCR. The AML1-ETO t(8;21)(q22;q22) assay allows also the detection and quantification of ABL as a endogenous control gene. Standard curves of known amounts of both the endogenous control and the gene ...
Manufactured by:CLONIT srl based inAbbiategrasso, ITALY
The PML-RARA t(15;17)(q22;q21) is an in vitro diagnostic test for the detection and identification of the PML-RARA gene fusions resulting from the t(15;17)(q22;q21) , by multiplex one-step Real-Time PCR. The PML-RARA t(15;17)(q22;q21) allows also the detection and quantification of ABL as a endogenous control gene. Standard curves of known amounts of both the endogenous control and the gene ...
by:Oncodesign based inDijon, FRANCE
Oncodesign’s Pharmimage® technology module is a pharmaco-imaging module designed to monitor the effect of treatments and to define effective translational biomarkers in precision medicine. It includes translational, optical (bioluminescence, fluorescence), functional and molecular (MRI, PET, SPECT, CT scanner, MRI/PET coupling) multi-modal imaging capabilities, adapted to small rodents ...
Manufactured by:Endodiag based inParis, FRANCE
Endodiag has built a regulatory compliant biobank of more than 1000 human biological samples, including fixed biopsies, serum, plasma and peritoneal fluid samples, as well as endometriosis primary cell cultures and endometriosis derived cell lines. These samples are annotated with patients’ clinical data. EndoBiobank® together with the company’s established clinical network of ...
Manufactured by:cellvie Inc. based inHouston, TEXAS (USA)
Mitochondria dysfunction has been tied to a host of medical conditions, including heart disease, stroke, diabetes, Parkinson's and Alzheimer's. But mitochondria have, for the most part, eluded treatment. This compelled Dr. McCully and his team to think in new ...
by:Pure Biologics SA based inWroclaw, POLAND
In cancer, a balance between immune system effector and regulatory cells becomes disturbed. Regulatory T cells inhibit the activity of effector cells, including NK cells, a process known as immunosuppression. The PB003 (PureActivator) project embraces a novel approach, aiming to develop a drug based on a bimodal fusion protein, which synergistically activates NK cells and minimizes ...
Manufactured by:Therawis based inMunich, GERMANY
The acute SARS-CoV-2 infection is diagnosed routinely through PCR-based detection of viral RNA from nasopharyngeal swabs. Additionally, direct antigen detection of viral proteins is now available. The specific detection by PCR has a high sensitivity and specificity but delivers a false-negative rate of up to 38 % at the time of symptoms (Kucirka et al. 2020). The sensitivity and specificity of ...